57
Views
2
CrossRef citations to date
0
Altmetric
Letter

Docetaxel-loaded solid lipid nanoparticles as a basis for a targeted and dose-sparing personalized breast cancer treatment strategy

, , , , , & show all
Pages 2417-2421 | Published online: 25 Mar 2015

References

  • RampurwalaMMRocqueGBBurkardMEUpdate on adjuvant chemotherapy for early breast cancerBreast Cancer (Auckl)2014812513325336961
  • KurianAWLichtensztajnDYKeeganTHNelsonDOClarkeCAGomezSLUse of and mortality after bilateral mastectomy compared with other surgical treatments for breast cancer in California, 1998–2011JAMA201431290291425182099
  • BurkiTKIncreases in bilateral mastectomy for breast cancerLancet Oncol201415e480
  • HalstedCPBensonJRJatoiIA historical account of breast cancer surgery: beware of local recurrence but be not radicalFuture Oncol2014101649165725145433
  • BerbersJvan BaardwijkAHoubenRReconstruction: before or after postmastectomy radiotherapy? A systematic review of the literatureEur J Cancer2014502752276225168640
  • Hugenholtz-WamstekerW1RobbesonCNijsJHoelenWMeeusMThe effect of docetaxel on developing oedema in patients with breast cancer: a systematic reviewEur J Cancer Care (Engl)10272014 Epub ahead of print
  • YuanQHanJCongWDocetaxel-loaded solid lipid nanoparticles suppress breast cancer cells growth with reduced myelosuppression toxicityInt J Nanomedicine201494829484625378924
  • World Health OrganizationCancer Fact sheet 297. Key facts Available from: http://www.who.int/mediacentre/factsheets/fs297/en/Accessed November 14, 2012
  • Federal Research Institute for Health Organization and Informatics of the Ministry of Health of the Russian FederationAnnual Statistics, 2012. Socially important diseases in the Russian populationMoscow2013 Available from: http://www.mednet.ru/en.htmlAccessed November 14, 2014

References

  • JemalABrayFCenterMMFerlayJWardEFormanDGlobal cancer statisticsCA: a cancer journal for clinicians2011612699021296855
  • FerlayJShinHRBrayFFormanDMathersCParkinDMEstimates of worldwide burden of cancer in 2008: GLOBOCAN 2008Int J Cancer2010127122893291721351269
  • RampurwalaMMRocqueGBBurkardMEUpdate on adjuvant chemotherapy for early breast cancerBreast cancer (Auckl)2014812513325336961
  • SaloustrosEMavroudisDGeorgouliasVPaclitaxel and docetaxel in the treatment of breast cancerExpert Opin Pharmacother20089152603261618803448
  • CrownJO'LearyMOoiWSDocetaxel and paclitaxel in the treatment of breast cancer: a review of clinical experienceOncologist20049Suppl 2243215161988
  • BakerJAjaniJScotteFDocetaxel-related side effects and their managementEur J Oncol Nurs2009131495919201649
  • HwangHYKimISKwonICKimYHTumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticlesJ Control Release20081281233118374444
  • EsmaeiliFDinarvandRGhahremaniMHOstadSNEsmailyHAtyabiFCellular cytotoxicity and in-vivo biodistribution of docetaxel poly(lactide-co-glycolide) nanoparticlesAnticancer Drugs2010211435219809300
  • YanasarnNSloatBRCuiZNanoparticles engineered from lecithin-in-water emulsions as a potential delivery system for docetaxelInt J Pharm2009379117418019524029
  • ImmordinoMLBrusaPArpiccoSStellaBDosioFCattelLPreparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing docetaxelJ Control Release200391341742912932719
  • ElsabahyMPerronMEBertrandNYuGELerouxJCSolubilization of docetaxel in poly(ethylene oxide)-block-poly(butylene/styrene oxide) micellesBiomacromolecules2007872250225717579476
  • LiuJZahediPZengFAllenCNano-sized assemblies of a PEG-docetaxel conjugate as a formulation strategy for docetaxelJ Pharm Sci20089783274329018064681
  • ZhengDLiDLuXFengZEnhanced antitumor efficiency of docetaxel-loaded nanoparticles in a human ovarian xenograft model with lower systemic toxicities by intratumoral deliveryOncol Rep201023371772420127011
  • GaoYYangRZhangZChenLSunZLiYSolid lipid nanoparticles reduce systemic toxicity of docetaxel: performance and mechanism in animalNanotoxicology20115463664921306192
  • PuriALoomisKSmithBLipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinicCrit Rev Ther Drug Carrier Syst200926652358020402623
  • PorterCJTrevaskisNLCharmanWNLipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugsNat Rev Drug Discov20076323124817330072
  • YuanQHanJCongWDocetaxel-loaded solid lipid nanoparticles suppress breast cancer cells growth with reduced myelosuppression toxicityInt J Nanomedicine201494829484625378924
  • ZhangPChenLZhangZLinLLiYPharmacokinetics in rats and efficacy in murine ovarian cancer model for solid lipid nanoparticles loading docetaxelJ Nanosci Nanotechnol201010117541754421137978